Loading...
Risk Assessment generated by a regulatory process (RA)
  |  
BCH-RA-DE-108796-3   |   PDF   |   Print   |  
published: 28 Sep 2015 last updated: 06 Aug 2020
General Information
6786-01-0164 (adv. 42010.0164); Summary of the risk assessment of a deliberate release (field trial) of the genetically modified black nightshade (Solanum nigrum L.) S03/140-5 and S03/144-2, issued by the German Competent Authority
EN
02 Jun 2005
Risk assessment details
  • Black Nightshade with reduced pathogenesis-related protein 1S synthesis
    | Max Planck Institute for Chemical Ecology(MPICE) | Resistance to antibiotics (Hygromycin), Resistance to diseases and pests
  • Black Nightshade with reduced pathogenesis-related protein 1S synthesis.
    | Max Planck Institute for Chemical Ecology(MPICE) | Resistance to antibiotics (Hygromycin), Resistance to diseases and pests
Methodology and points to consider
The execution of this field trial is not expected to have a negative impact on human or animal health, or on the environment.
EN
EN
EN
Adverse effects on human or animal health or on the environment are not expected.
EN
EN
EN
One field site in Germany, for details refer to the German LMO/GMO location register (http://apps2.bvl.bund.de/stareg_web/localeSwitch.do?language=en&page=/showflaechen.do?)
EN
construct-specific PCR-based method
EN
Records referencing this document Show in search
Record type Field Record(s)
Country's Decision or any other Communication Risk assessment 1